Potential coagulation effects of preoperative complementary and alternative medicines

Alternative Therapies in Health and Medicine

Volumn 7, Issue 6, 2001, Pages 58-67

  Norred, C L ^a   Brinker, F ^a  

^a INNOVISION COMMUNICATIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANTICOAGULANT AGENT; ARACHIDONIC ACID; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; COLLAGEN; COUMARIN ANTICOAGULANT; CURCUMA LONGA EXTRACT; DICOUMAROL; FIBRIN; FIBRINOGEN; GINKGO BILOBA EXTRACT; GINKGOLIDE B; GINSENG EXTRACT; HERBACEOUS AGENT; ONION EXTRACT; PROTHROMBIN; QUININE SULFATE; SERTRALINE; THROMBOPLASTIN; UBIDECARENONE; UMBELLIFERONE; UNINDEXED DRUG; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING; DIET SUPPLEMENTATION; DRUG SAFETY; GLYCYRRHIZA; HEALTH FOOD; HEMOSTASIS; HERBAL MEDICINE; HUMAN; PHYTOTHERAPY; RISK ASSESSMENT; RISK FACTOR; THROMBOCYTE AGGREGATION INHIBITION;

ANTICOAGULANTS; BLOOD COAGULATION; COMPLEMENTARY THERAPIES; COUMARINS; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; HUMANS; PHYTOTHERAPY; PLATELET AGGREGATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; SELF MEDICATION;

EID: 0035157706     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (129)

1. New and old media used to distribute ASA's patient safety message about herbal medications
2. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey
3. Use of alternative therapies among emergency department patients
4. Alternative medicine use in presurgical patients
5. The incidence of herbal and selected nutraceutical use in surgical patients
6. Herbal medicines-current trends in anesthesiology practice, a hospital survey
7. Use of complementary and alternative medicines by surgical patients
8. Hemorrhage after the preoperative use of complementary and alternative medicines
9. Preoperative considerations with herbal medicines
10. Preanesthetic assessment, lesson 180: The patient on herbal medicines, part 1
11. Herbal medicinals. Selected clinical considerations focusing on known or potential drug-herb interactions
12. Herbs as medicines
13. Unsafe and potentially safe herbal therapies
14. Safety issues with herbal medicine
15. Safety issues with herbal products
16. Some popular OTC herbals can interact with anticoagulant therapy
17. Potential interactions between alternative therapies and warfarin
18. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies
19. Dietary supplement adverse reactions and interactions: 2000 Update
20. Herbal medicine for the treatment of cardiovascular disease
21. Botanical medicine - A modern perspective
22. Where to with herbals?
23. Adverse reactions and interactions with herbal medicines. Part 2: Drug interactions
24. Herb-drug interactions
25. Clinically significant drug interactions
26. Inhaled anesthetics
27. What changes drug metabolism in critically ill patients?
28. Mood altering drugs and integrative medicine: What we don't know, what we need to know, and how we can find out
29. Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential
30. The metabolism of coumarin
31. Sweet clover poisoning in dairy cattle in California
32. Seopoletin as a trace constituent of compounded feeds and the lack of an association with the haemorrhagic bowel syndrome in the pig
33. Isolation of herniarin and other constituents from Matricaria chamomila flowers
34. Toxicity of medicinal herbal preparations
35. Efficacy of homeopathic arnica: A systemic review of placebo-controlled clinical trials
36. Drug interactions in anesthesia
37. Drug interactions as a cause of overanticoagulation bleedings in Chinese patients receiving warfarin
38. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation
39. Bromelian, the enzyme complex of pineapple (Ananas comosus) and its clinical application: An update
40. Hemorrhagic diathesis caused by drinking an herbal tea
41. Anti-platelet action of GU-7, a 3-arylcoumarin derivative, purified from Glycrrhizae radix
42. Pseudoiperaldosteronismo secondario and intossicazione da liquirizia associato a gastrite emorrgica
43. Effect of ginger (Zingiber officinale Rosc) and fenugreek (Trigonella foenumgraecum I) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease
44. Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis (Leguminosae) seeds and their major alkaloids in alloxan-diabetic and normal rats
45. Inhibition of NAD(P)H: Quinone acceptor oxidoreductase by flavones a structure-activity study
46. Studies on scutellariae radix XII. Anti-thrombic actions of various gavonoids from scutellariae radix
47. Early clinical studies with lapachol
48. Potentiation of warfarin by dong quai
49. 2
50. Dannggui (Angelica sinesis) affects the pharmacodynamics but not the pharmacokinetics of warfarin in rabbits
51. The effect of a medicinal Chinese herb on platelet function
52. Chinese herbs and warfarin potentiation by 'danshen'
53. Warfarin danshen interaction
54. Traditional remedies and food supplements: A 5-year toxicological study (1991-1995)
55. Analytische und biologische Untersuchungen an Salicaceen-Wirkstoffen, insbesondere an Salicin
56. Herbal medicine precipitating massive haemolysis
57. Garlic and the risk of TURP bleeding
58. Garlic as a possible risk for postoperative bleeding
59. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: A case report
60. Aqueous extracts of onion, garlic, and ginger inhibit platelet aggregation and alter arachidonic acid metabolism
61. Effect of garlic (Allium sativum) on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients with coronary artery disease
62. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects
63. Effect of garlic on human platelet aggregation in vitro
64. Inhibitory effect of orally administered inclusion complex of garlic oil on platelet aggregation in man
65. Characterization of a potent inhibitor of platelet aggregation and release reaction isolated from Allium sativum (garlic)
66. Antiplatelet constituents of garlic and onion
67. Inhibition of whole blood platelet-aggregation by compounds in garlic clove extracts and commercial garlic products
68. Effects of garlic extract and 3 pure components isolated from it on human platelet aggregation, arachidonate metabolism, release reaction and platelet ultrastructure
69. Inhibition of platelet aggregation and thromboxane synthesis by onion and garlic
70. Ginkgo, part 1: History, use, and pharmacologic properties
71. Effect of a ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet activating factor in man
72. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract
73. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion
74. Association of Ginkgo biloba with intracerebral hemorrhage
75. Extract of feverfew inhibits prostaglandin biosynthesis
76. The active principle in feverfew
77. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in vitro
78. An extract of feverfew inhibits interaction of human platelets with collagen substrates
79. Effects of an extract of feverfew on endothelial cell integrity and on CAMP in rabbit perfused aorta
80. Platelet aggregation in patients using fever few for migraine
81. Effect of dried ginger on human platelet function
82. Ginger root-a new antiemetic. The effect of ginger root on postoperative nausea and vomiting after major gynecological surgery
83. Zingiber officinale (Ginger)-an antiemetic for day case surgery
84. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation
85. Antiplatelet principles from a food spice clove (Syzygium Aromaticum L)
86. Effects of Vaccinium myrtillus anthocyanosides on prostacyclin-like activity in rat arterial tissue
87. Inhibition of aggregation and and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin
88. Anti-platelet aggregation principles from the bark of fraxinus japonica blume
89. Horse chestnut seed extract for the treatment of chronic venous insufficiency
90. Inhibition of thromboxane A2 biosynthesis in vitro by the main components of Crategus oxycantha (hawthrn) flower heads
91. Antithrombotic action of the kava pyrone (+)- kavain prepared from Piper methysticum on human platelets
92. Clinical and experimental study on the longterm effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production
93. The metabolism of dihomo-linolenic acid in man
94. Platelet anti-aggregating activity of Taraxacum officinale Webber
95. Antiplatelet effects of capsaicin
96. Inhibition of platelet aggregation by apigenin from Apium graveolens Asia Pac J Pharmacol
97. Szechwan purpura
98. In vitro inhibition of platelet aggregation with low, dalton compounds from aqueous dialysates of edible fungi
99. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets
100. Enhanced fibrinolytic activity after capsicum ingestion
101. Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease
102. Platelet activating factor antagonistic activity of ginsensosides
103. Pharmacological study on Panax ginseng CA Meyer. III. Effects of red ginseng on experimental disseminated intravascular coagulation. (2) Effects of ginsenosides on blood coagulative and fibrinolytic systems
104. Antiplatelet Antiplatelet components in Panax ginseng
105. Probable interaction between warfarin and ginseng
106. Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats
107. Green tea monograph
108. Probable antagonism of warfarin by green tea
109. Glucosamine sulfate and chondroitin sulfates
110. Effects of the treatment with matrix on elderly people with chronic articular degeneration
111. Anticoagulants from marine algae
112. Isolation of highly purified 'fucoidan' from Eisenia bicyclis and its anticoagulant and antitumor activities
113. Dose response of dietary fish oil supplementation on platelet adhesion
114. Effect of vitamin E on the anticoagulant response to warfarin
115. Experimental thrombosis model induced by free radicals
116. Drugs acting on the haemostatic system
117. Why patients use alternative medicine: Results of a national study
118. Advising patients who seek alternative medical therapies
119. Factors that shape alternative medicine: The role of the alternative medicine research community